Novel therapies for graft versus host disease with a focus on cell therapies

Graft versus host disease (GVHD) can occur at any period post allogeneic hematopoietic stem cell transplantation as a common clinical complication contributing to significant morbidity and mortality. Acute GVHD develops in approximately 30-50% of patients receiving transplants from matched related d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeiser, Robert, Ringden, Olle, Sadeghi, Behnam, Gonen-Yaacovi, Gil, Segurado, Oscar G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585098/
https://www.ncbi.nlm.nih.gov/pubmed/37868964
http://dx.doi.org/10.3389/fimmu.2023.1241068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585098/
https://www.ncbi.nlm.nih.gov/pubmed/37868964
http://dx.doi.org/10.3389/fimmu.2023.1241068

Ejemplares similares